Company Filing History:
Years Active: 2018-2023
Title: Juhana Honkavaara: Innovator in Psychoactive Compositions
Introduction
Juhana Honkavaara is a notable inventor based in Helsinki, Finland. He has made significant contributions to the field of pharmacology, particularly in the development of compositions for sedation and anesthesia. With a total of 2 patents, Honkavaara's work is recognized for its innovative approach to enhancing medical treatments.
Latest Patents
Honkavaara's latest patents include compositions comprising substituted benzofuroquinolizine and psychoactive drugs. The first patent relates to compositions for use in sedation and/or anesthesia, where the composition comprises MK-467 and a psychoactive drug selected from opioids, benzodiazepines, NMDA receptor antagonists, and combinations thereof. This composition is administered using parenteral extravascular administration to a subject in need of sedation and/or anesthesia. The second patent focuses on compositions that facilitate the absorption and distribution of α-adrenergic agonists. This composition also comprises a substituted benzofuroquinolizine and an α-adrenoceptor agonist selected from substituted imidazoles and substituted thiazines, administered similarly to aid in sedation.
Career Highlights
Honkavaara is currently associated with Vetcare Oy, a company that specializes in veterinary pharmaceuticals. His work at Vetcare Oy has allowed him to apply his innovative ideas in a practical setting, contributing to advancements in veterinary medicine.
Collaborations
Throughout his career, Honkavaara has collaborated with esteemed colleagues such as Outi Vainio and Marja Raekallio. These collaborations have fostered a productive environment for research and development in the field of pharmacology.
Conclusion
Juhana Honkavaara's contributions to the field of psychoactive compositions highlight his innovative spirit and dedication to improving medical practices. His patents reflect a commitment to advancing sedation and anesthesia techniques, making a significant impact in both human and veterinary medicine.